Morgan Stanley
HCM icon

Morgan Stanley’s HUTCHMED HCM Stock Holding History

Morgan Stanley’s Portfolio HCM Stock Details HCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.9K Sell
8,545
-2,805
-25% -$35.5K ﹤0.01% 6289
2026
Q1 		$170K Sell
11,350
-797
-7% -$11.7K ﹤0.01% 5942
2025
Q4 		$162K Sell
12,147
-3,030
-20% -$44.3K ﹤0.01% 6008
2025
Q3 		$239K Sell
15,177
-2,412
-14% -$39.7K ﹤0.01% 5819
2025
Q2 		$265K Sell
17,589
-2,607
-13% -$38.1K ﹤0.01% 5738
2025
Q1 		$304K Sell
20,196
-6,315
-24% -$93.4K ﹤0.01% 5553
2024
Q4 		$382K Sell
26,511
-70,280
-73% -$1.26M ﹤0.01% 5534
2024
Q3 		$1.89M Buy
96,791
+12,954
+15% +$234K ﹤0.01% 4691
2024
Q2 		$1.44M Buy
83,837
+50,521
+152% +$932K ﹤0.01% 4769
2024
Q1 		$560K Sell
33,316
-4,546
-12% -$69K ﹤0.01% 5264
2023
Q4 		$686K Sell
37,862
-8,316
-18% -$151K ﹤0.01% 5149
2023
Q3 		$782K Buy
46,178
+2,752
+6% +$39.4K ﹤0.01% 4937
2023
Q2 		$521K Sell
43,426
-29,380
-40% -$401K ﹤0.01% 5190
2023
Q1 		$948K Sell
72,806
-73,187
-50% -$1.2M ﹤0.01% 4893
2022
Q4 		$2.16M Sell
145,993
-99,607
-41% -$1.09M ﹤0.01% 4415
2022
Q3 		$2.17M Buy
245,600
+11,568
+5% +$146K ﹤0.01% 4369
2022
Q2 		$2.96M Buy
234,032
+46,997
+25% +$598K ﹤0.01% 4226
2022
Q1 		$3.54M Buy
187,035
+7,091
+4% +$181K ﹤0.01% 4042
2021
Q4 		$6.31M Sell
179,944
-76,680
-30% -$2.49M ﹤0.01% 3467
2021
Q3 		$9.39M Buy
256,624
+56,445
+28% +$2.22M ﹤0.01% 2965
2021
Q2 		$7.86M Sell
200,179
-21,888
-10% -$632K ﹤0.01% 3274
2021
Q1 		$6.27M Sell
222,067
-47,949
-18% -$1.53M ﹤0.01% 3173
2020
Q4 		$8.65M Buy
270,016
+183,672
+213% +$5.65M ﹤0.01% 2668
2020
Q3 		$2.79M Buy
86,344
+30,827
+56% +$961K ﹤0.01% 3339
2020
Q2 		$1.53M Sell
55,517
-50,257
-48% -$1.09M ﹤0.01% 3835
2020
Q1 		$1.89M Sell
105,774
-23,967
-18% -$578K ﹤0.01% 3417
2019
Q4 		$3.25M Buy
129,741
+102,597
+378% +$2.25M ﹤0.01% 3639
2019
Q3 		$484K Buy
27,144
+3,156
+13% +$65.7K ﹤0.01% 4694
2019
Q2 		$528K Sell
23,988
-17,504
-42% -$500K ﹤0.01% 4583
2019
Q1 		$1.27M Sell
41,492
-10,607
-20% -$265K ﹤0.01% 3951
2018
Q4 		$1.2M Buy
52,099
+48,873
+1,515% +$1.52M ﹤0.01% 4145
2018
Q3 		$104K Sell
3,226
-14,623
-82% -$446K ﹤0.01% 5670
2018
Q2 		$538K Buy
17,849
+6,520
+58% +$207K ﹤0.01% 5050
2018
Q1 		$334K Buy
11,329
+11,197
+8,483% +$398K ﹤0.01% 5225
2017
Q4 		$5K Sell
132
-6,165
-98% -$197K ﹤0.01% 6334
2017
Q3 		$171K Sell
6,297
-668
-10% -$16.4K ﹤0.01% 5416
2017
Q2 		$163K Buy
6,965
+6,818
+4,638% +$140K ﹤0.01% 5440
2017
Q1 		$3K Buy
+147
New +$2.21K ﹤0.01% 6419
2016
Q4 		– Sell
-35,349
Closed -$421K – 6537
2016
Q3 		$421K Buy
+35,349
New +$452K ﹤0.01% 4625
2016
Q2 		– Sell
-11
Closed – – 6563
2016
Q1 		$0 Buy
+11
New +$147 ﹤0.01% 6632

Other funds holding HCM

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AG
AIA Group Hong Kong $7.95B AUM 28.94% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
XC
XY Capital Central, Hong Kong $104M AUM 8% 1-Year Est. Return

Morgan Stanley's HCM Position: Q2 2026 in Review

Morgan Stanley reduced its HUTCHMED (HCM) stake by 25% in Q2 2026, selling an estimated $35.5K and leaving 8,545 shares worth $91.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6289.

Morgan Stanley first reported a position in HCM in Q1 2016 and has held it in 40 quarters since. The position peaked at $9.39M in Q3 2021. 56 funds tracked by Wall St. Rank hold HCM as of Q2 2026.

  • Morgan Stanley held 8,545 shares of HUTCHMED worth $91.9K as of Q2 2026.
  • Morgan Stanley sold 2,805 HUTCHMED shares in Q2 2026, an estimated $35.5K.
  • HUTCHMED made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6289 holding.
  • Morgan Stanley first reported a position in HUTCHMED in Q1 2016 and has held it in 40 quarters since.
  • Morgan Stanley's HUTCHMED position peaked at $9.39M in Q3 2021.
  • 56 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.